Efficacy of Liposomal Bupivacaine Versus 0.25% Bupivacaine for Laparoscopic Urologic Surgery

• Status: Completed
• Trial end date: 2013-12-01
• Target enrollment: 0
• Participant gender: All

Summary

A prospective, randomized comparison of bupivacaine to liposomal bupivacaine given by local injection at all the wound sites in patients undergoing robotic-assisted or laparoscopic urologic surgeries in an effort to determine which method reduced postoperative opioid use the most.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Knight, Richard, M.D.
• Treatments: Bupivacaine

Criteria

Inclusion Criteria:

• At least 18-years-old, undergoing laparoscopic urologic surgery.

Exclusion Criteria:

• Pregnant and/or nursing mothers.

• Allergy to bupivacaine.